Tekla Healthcare Investors is an asset management business based in the US. Tekla Healthcare Investors shares (HQH) are listed on the NYSE and all prices are listed in US Dollars.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $17.56 |
|---|---|
| 52-week range | $13.11 - $17.52 |
| 50-day moving average | $16.81 |
| 200-day moving average | $16.32 |
| Wall St. target price | N/A |
| PE ratio | 13.3282 |
| Dividend yield | $1.66 (10.6%) |
| Earnings per share (TTM) | $1.31 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $17.56 from 2024-07-03
| 1 week (2024-06-27) | 1.09% |
|---|---|
| 1 month (2024-06-04) | 4.65% |
| 3 months (2024-04-04) | 8.06% |
| 6 months (2024-01-04) | 2.57% |
| 1 year (2023-07-03) | 2.81% |
|---|---|
| 2 years (2022-07-01) | -7.43% |
| 3 years (2021-07-02) | 26 |
| 5 years (2019-07-03) | 2.67% |
Valuing Tekla Healthcare Investors stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Tekla Healthcare Investors's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Tekla Healthcare Investors's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 13x. In other words, Tekla Healthcare Investors shares trade at around 13x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
| Revenue TTM | $10 million |
|---|---|
| Gross profit TTM | $8.3 million |
| Return on assets TTM | -0.07% |
| Return on equity TTM | 7.34% |
| Profit margin | 730.94% |
| Book value | $19.91 |
| Market Capitalization | $883.9 million |
TTM: trailing 12 months
We're not expecting Tekla Healthcare Investors to pay a dividend over the next 12 months.
Over the last 12 months, Tekla Healthcare Investors's shares have ranged in value from as little as $13.1094 up to $17.52. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Tekla Healthcare Investors's is 0.744. This would suggest that Tekla Healthcare Investors's shares are less volatile than average (for this exchange).
Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. Abrdn Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.
Learn the basics of call options: what they are, how they work and examples.
These are the 10 best stocks to buy right now, trading on the Nasdaq and NYSE.
Features and fees to consider before you open an account with this trading platform.
Compare pros, cons, research tools and reviews for these two trading platforms.
What you need to know about investing in the leading indicator for the overall US stock market.
There are many ways to invest and grow $50K depending on your financial situation, personal needs and goals.
Take advantage of commission-free trading with stocks, ETFs and options with a flexible trading platform.
Webull is a broker with zero-commission trading and a suite of tools to help you invest.
Interactive Brokers has advanced charting tools but a high net requirement to qualify.
Check out the best-performing ETFs so far in 2024.